Descrizione del progetto
Genomica evolutiva per migliorare la medicina
La comprensione del meccanismo di evoluzione del genoma nel tempo è di fondamentale importanza per comprendere le basi genetiche delle malattie e la complessa interazione tra i geni, nonché per migliorare le terapie geniche. Come riesce il genoma a mitigare gli errori che emergono durante la replicazione del DNA? Esistono siti silenziosi in cui gli errori non hanno alcun impatto? Il progetto EvoGenMed, finanziato dal Consiglio europeo della ricerca, si propone di esplorare come gli errori possano portare a cambiamenti evolutivi e a nuovi tratti, e quanto sia forte questa selezione. Analizzando le mutazioni e le reti geniche, i ricercatori intendono sviluppare strumenti diagnostici migliori, identificare le mutazioni che causano malattie e trovare siti sicuri per l’inserimento di geni terapeutici.
Obiettivo
To make for better diagnostics and safer applications of genomics we need a better understanding of our genome and how it functions. Until recently we thought we knew: intergenic sequence must be largely “junk” and mutations that, for example, affect genes but not the protein (synonymous mutations) must be effectively neutral. This degenerate genome view accords with the nearly-neutral theory’s prediction that selection will be weaker when populations are small. But is this all there is to it? I shall investigate two new interrelated perspectives on genome evolution. First, I suggest that to mitigate errors, owing to our high error rates, our genome can be under stronger, not weaker, selection. Second, that errors might be a source of evolutionary novelty. Error mitigation, my team has shown, often involves selection on seemingly innocuous mutations such as synonymous changes. Remarkably, we discovered that selection to ensure error-proof splicing is possibly more prevalent on synonymous mutations when populations are small, making seemingly innocuous mutations stronger candidates for human diseases. I shall provide the first test of the new error-proofing perspective through comparative genomic analysis on synonymous site evolution. To investigate error as a source of novelty I shall consider whether expression piggy-backing (expression of a gene affecting its neighbors) forces rewiring of gene networks. Importantly, I shall translate our new understanding to enable better diagnostics and improved therapeutics. I shall develop a much-needed computer package to identify candidate disease-causing synonymous changes. In addition, knowing how synonymous sites modulate splicing will allow me to design better intronless transgenes. Transgenes must also be inserted in genomic regions immune to piggy-backing. I will examine transposable element related piggy-backing to characterize “safe” sites for therapeutic gene insertion and mammalian transgenesis more generally.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Meccanismo di finanziamento
ERC-ADG - Advanced GrantIstituzione ospitante
BA2 7AY Bath
Regno Unito